The Global Pen Needles Market size is expected to reach $3.1 billion by 2030, rising at a market growth of 9.4% CAGR during the forecast period. In the year 2022, the market attained a volume of 86,930.9 thousand Units experiencing a growth of 9.1% (2019-2022).
The trend toward self-administration empowers patients to manage their health and treatment independently. This is particularly evident in diabetes management, where self-administration of insulin has become the norm for many patients. Therefore, Insulin segment generated $1,122.2 million revenue in the market in 2022. As a result, self-administration can lead to cost savings for healthcare systems by reducing the need for frequent clinical visits and healthcare professional assistance. This is beneficial, especially in healthcare settings with limited resources.
The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In May, 2023, Embecta Corp. came into partnership with Tidepool, to develop an automated insulin delivery system for the treatment of type 2 diabetes. The two companies would combine their respective offerings to facilitate glucose management within the patients to achieve the aim of their partnership. Moreover, In November, 2021, Terumo Corporation signed a partnership with Diabeloop, to provide Automated Insulin Delivery solutions to European customers. The partnership expands the two company's geographical footprint.
Based on the Analysis presented in the KBV Cardinal matrix; Novo Nordisk A/S is the forerunner in the Market. In September, 2023, Novo Nordisk A/S came into partnership with Aspen Pharmacare Holdings Limited, a global pharmaceutical company. The partnership aimed at providing affordable human insulin to patients within the African continent. Companies such as Terumo Corporation, B. Braun Melsungen AG and Embecta Corp. are some of the key innovators in the Market.
COVID-19 Impact Analysis
The COVID-19 pandemic had a significant impact on the market. With the pandemic limiting in-person healthcare visits, many people with diabetes and other chronic conditions turned to telemedicine for remote consultations and prescription renewals. As a result, the demand for self-administered medical devices like pen needles increased to facilitate home-based care. The pandemic disrupted global supply chains, leading to delays in the manufacturing and distribution of medical devices, including pen needles. This caused temporary shortages and distribution challenges for these critical healthcare products. This likely led to a surge in the adoption of these needles. Due to such factors, the market will uplift after the pandemic.
Market Growth Factors
Expansion of technological advancements
Special coatings on pen needles can make the injection process smoother and less painful. These coatings can help the needle glide through the skin more easily. Technological advancements have enabled manufacturers to offer various pen needles with varying specifications to meet individual patient needs. These needles are often compatible with different pen devices, enhancing their versatility. Improved manufacturing processes have increasing precision and quality in pen needle production, ensuring consistent and reliable performance. Some pen devices and pen needles are integrated with digital health technologies, allowing patients to track their injections and monitor their health more effectively. As technology advances, the market will likely see further growth and innovation.
Growing prevalence of diabetes
Modern lifestyles characterized by sedentary behavior, unhealthy dietary habits, and increased stress levels have contributed to a rise in obesity and, consequently, type 2 diabetes. As the global population ages, the risk of developing type 2 diabetes increases. Elderly adults are more susceptible to this condition. Obesity is a substantial risk factor for type 2 diabetes. Global obesity has led to a higher incidence of diabetes cases. Increasing urbanization has led to more people leading sedentary lives, which can contribute to insulin resistance and the development of type 2 diabetes. The increasing prevalence of diabetes has a significant impact on the market, driving both the development of advanced pen needles and the expansion of their use in various healthcare settings.
Market Restraining Factors
Preference for alternative drug delivery method
The preference for alternative drug delivery methods, especially for specific medications, can result in competition for market share with pen needles. Manufacturers must adapt to changing preferences and innovate to remain competitive. The market may become saturated, especially in regions with prevalent or preferred alternative delivery methods. Manufacturers need to diversify their product offerings. Some patients struggle with adherence to injection regimens, leading healthcare providers to explore alternative methods that improve patient compliance. This requires patient education and support. The above factors will challenge market growth in the coming years.
Type Outlook
On the basis of type, the market is segmented into standard pen needles and safety pen needles. In 2022, the standard pen needles segment dominated the market with the maximum revenue share. Standard pen needles are designed for routine injections and come in various specifications to meet the needs of different patients. Standard pen needles are intended for one-time use. The needle length and gauge choice are based on individual preferences, body type, and healthcare provider recommendations. Some individuals prefer shorter and thinner needles for comfort, while others require longer needles for proper subcutaneous insulin delivery.
Setting Outlook
Based on setting, the market is divided into homecare, hospitals & clinics, and others. The hospitals & clinics segment garnered a significant revenue share in the market in 2022. Hospitals and clinics use pen needles extensively for diabetes management. This training ensures that patients can safely and effectively self-administer medications. Using pen needles in hospitals and clinics is crucial for providing effective and convenient subcutaneous medication administration to patients with various medical conditions. The patient's needs and the medication administered determine the pen needle type, length, and gauge choice.
Application Outlook
By application, the market is classified into insulin, glucagon-like-peptide-1 (GLP-1), growth hormone, osteoporosis, and others. In 2022, the insulin segment registered the highest revenue share in the market. Insulin therapy involves the subcutaneous administration of insulin, which means injecting insulin into the fatty tissue beneath the skin. Using pen needles in insulin therapy allows individuals to personalize their diabetes management based on their lifestyle, insulin regimen, and healthcare provider recommendations. Insulin therapy with pen needles is crucial for individuals with diabetes to maintain proper blood glucose control and prevent complications associated with high or low blood sugar levels.
Length Outlook
Based on length, the market is fragmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. The 12mm segment projected a significant revenue share in the market in 2022. People with diabetes, both type 1 and type 2, often use 12mm pen needles to self-administer insulin. The longer length of these needles ensures that the insulin is delivered into the subcutaneous tissue, even in individuals with thicker skin or more subcutaneous fat. Longer needles can help reduce the risk of medication leakage or being injected too shallowly, ensuring that the medication is effectively delivered to the intended tissue layer.
Mode of Purchase Outlook
On the basis of mode of purchase, the market is categorised into prescription-based, over the counter, online purchase, and others. In 2022, the over the counter segment generated the largest revenue share in the market. Over-the-counter (OTC) pen needles are pen needles that can be purchased without the need for a prescription from a healthcare provider. The availability of OTC pen needles provides a suitable and accessible option for individuals who require these devices for their medical treatment, particularly those with diabetes who need insulin administration.
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region dominated the market with the maximum revenue share. The growth of the North America market is primarily driven by factors such as the high prevalence of diabetes, the increase in the adoption of insulin pens, and the rise in awareness regarding the benefits of pen needles over traditional syringes. Moreover, the availability of a various range of pen needles with different lengths, gauges, and designs and the presence of established market players such as Becton, Dickinson and Company, Novo Nordisk A/S, and Owen Mumford are contributing to the growth of the market in North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Embecta Corp., Novo Nordisk A/S, Ypsomed AG, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Owen Mumford Limited, Arkray, Inc., UltiMed, Inc. and Allison Medical, Inc.
Recent Strategies Deployed in Pen Needles Market
Partnerships, Collaborations & Agreements:
Sep-2023: Novo Nordisk A/S came into partnership with Aspen Pharmacare Holdings Limited, a global pharmaceutical company. The partnership aimed at providing affordable human insulin to patients within the African continent.
May-2023: Embecta Corp. came into partnership with Tidepool, an AI-driven diabetes treatment solutions provider, to develop an automated insulin delivery system for the treatment of type 2 diabetes. The two companies would combine their respective offerings to facilitate glucose management within the patients to achieve the aim of their partnership.
Nov-2021: Terumo Corporation signed a partnership with Diabeloop, a therapeutic AI solutions provider, to provide Automated Insulin Delivery solutions to European customers. The partnership expands the two company's geographical footprint.
Product Launches and Product Expansions:
Oct-2022: Ypsomed AG released YpsoMate 5.5, an autoinjector platform for liquid medications with volumes within the 1.5 to 5.5 ml range. The product facilitates the self-administration of medicines to treat autoimmune diseases.
Sep-2022: Terumo Corporation announced the launch of FineGlide, a Sterile Pen Needle for facilitating regular insulin injections. The product has a 3-bevel sharp needle and a reliable silicone surface along with Thin Wall Technology for increasing flow rate that facilitates lesser injection force.
Dec-2021: Ypsomed AG introduced YpsoMate On, an autoinjector for prefilled syringes. The product is connectivity-enabled and can provide effective treatment for chronic diseases.
Dec-2021: Owen Mumford Limited announced the launch of Unifine Ultra, a home-use pen needle. The needle features an ergonomic design for facilitating easy use. Additionally, the needle includes Owen Mumford's SafeControl Technology which is used to secure both ends of the needle, thereby facilitating increased patient compliance.
Mergers & Acquisition:
Oct-2023: Novo Nordisk A/S acquired Biocorp Production, a French medical device manufacturer. The acquisition strengthens Novo Nordisk's devices and delivery solutions.
Geographical Expansions:
Mar-2023: Novo Nordisk A/S expanded its geographical footprint by opening a new R&D facility in Boston, United States. The new facility would serve as the premier US-based research and development activities hub for Novo Nordisk.
Scope of the Study
Market Segments covered in the Report:
By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)
- Standard Pen Needles
- Safety Pen Needles
By Setting (Volume, Thousand Units, USD Billion/Million, 2019-2030)
- Homecare
- Hospitals & Clinics
- Others
By Application (Volume, Thousand Units, USD Billion/Million, 2019-2030)
- Insulin
- Glucagon-like-Peptide-1 (GLP-1)
- Growth Hormone
- Osteoporosis
- Others
By Length
- 8mm
- 6mm
- 5mm
- 10mm
- 12mm
- 4mm
By Mode of Purchase (Volume, Thousand Units, USD Billion/Million, 2019-2030)
- Over the Counter
- Prescription-based
- Online Purchase
- Others
By Geography (Volume, Thousand Units, USD Billion/Million, 2019-2030)
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Embecta Corp.
- Novo Nordisk A/S
- Ypsomed AG
- B. Braun Melsungen AG
- Terumo Corporation
- Nipro Corporation
- Owen Mumford Limited
- Arkray, Inc.
- UltiMed, Inc.
- Allison Medical, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global Pen Needles Market, by Type
- 1.4.2 Global Pen Needles Market, by Setting
- 1.4.3 Global Pen Needles Market, by Application
- 1.4.4 Global Pen Needles Market, by Length
- 1.4.5 Global Pen Needles Market, by Mode of Purchase
- 1.4.6 Global Pen Needles Market, by Geography
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.2.4 Geographical Expansions
- 4.3 Market Share Analysis, 2022
- 4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2019, Feb - 2023, Sep) Leading Players
- 4.5 Porter Five Forces Analysis
Chapter 5. Global Pen Needles Market by Type
- 5.1 Global Standard Pen Needles Market by Region
- 5.2 Global Safety Pen Needles Market by Region
Chapter 6. Global Pen Needles Market by Setting
- 6.1 Global Homecare Market by Region
- 6.2 Global Hospitals & Clinics Market by Region
- 6.3 Global Others Market by Region
Chapter 7. Global Pen Needles Market by Application
- 7.1 Global Insulin Market by Region
- 7.2 Global Glucagon-like-Peptide-1 (GLP-1) Market by Region
- 7.3 Global Growth Hormone Market by Region
- 7.4 Global Osteoporosis Market by Region
- 7.5 Global Others Market by Region
Chapter 8. Global Pen Needles Market by Length
- 8.1 Global 8mm Market by Region
- 8.2 Global 6mm Market by Region
- 8.3 Global 5mm Market by Region
- 8.4 Global 10mm Market by Region
- 8.5 Global 12mm Market by Region
- 8.6 Global 4mm Market by Region
Chapter 9. Global Pen Needles Market by Mode of Purchase
- 9.1 Global Over the Counter Market by Region
- 9.2 Global Prescription-based Market by Region
- 9.3 Global Online Purchase Market by Region
- 9.4 Global Others Market by Region
Chapter 10. Global Pen Needles Market by Region
- 10.1 North America Pen Needles Market
- 10.1.1 North America Pen Needles Market by Type
- 10.1.1.1 North America Standard Pen Needles Market by Region
- 10.1.1.2 North America Safety Pen Needles Market by Region
- 10.1.2 North America Pen Needles Market by Setting
- 10.1.2.1 North America Homecare Market by Country
- 10.1.2.2 North America Hospitals & Clinics Market by Country
- 10.1.2.3 North America Others Market by Country
- 10.1.3 North America Pen Needles Market by Application
- 10.1.3.1 North America Insulin Market by Country
- 10.1.3.2 North America Glucagon-like-Peptide-1 (GLP-1) Market by Country
- 10.1.3.3 North America Growth Hormone Market by Country
- 10.1.3.4 North America Osteoporosis Market by Country
- 10.1.3.5 North America Others Market by Country
- 10.1.4 North America Pen Needles Market by Length
- 10.1.4.1 North America 8mm Market by Country
- 10.1.4.2 North America 6mm Market by Country
- 10.1.4.3 North America 5mm Market by Country
- 10.1.4.4 North America 10mm Market by Country
- 10.1.4.5 North America 12mm Market by Country
- 10.1.4.6 North America 4mm Market by Country
- 10.1.5 North America Pen Needles Market by Mode of Purchase
- 10.1.5.1 North America Over the Counter Market by Country
- 10.1.5.2 North America Prescription-based Market by Country
- 10.1.5.3 North America Online Purchase Market by Country
- 10.1.5.4 North America Others Market by Country
- 10.1.6 North America Pen Needles Market by Country
- 10.1.6.1 US Pen Needles Market
- 10.1.6.1.1 US Pen Needles Market by Type
- 10.1.6.1.2 US Pen Needles Market by Setting
- 10.1.6.1.3 US Pen Needles Market by Application
- 10.1.6.1.4 US Pen Needles Market by Length
- 10.1.6.1.5 US Pen Needles Market by Mode of Purchase
- 10.1.6.2 Canada Pen Needles Market
- 10.1.6.2.1 Canada Pen Needles Market by Type
- 10.1.6.2.2 Canada Pen Needles Market by Setting
- 10.1.6.2.3 Canada Pen Needles Market by Application
- 10.1.6.2.4 Canada Pen Needles Market by Length
- 10.1.6.2.5 Canada Pen Needles Market by Mode of Purchase
- 10.1.6.3 Mexico Pen Needles Market
- 10.1.6.3.1 Mexico Pen Needles Market by Type
- 10.1.6.3.2 Mexico Pen Needles Market by Setting
- 10.1.6.3.3 Mexico Pen Needles Market by Application
- 10.1.6.3.4 Mexico Pen Needles Market by Length
- 10.1.6.3.5 Mexico Pen Needles Market by Mode of Purchase
- 10.1.6.4 Rest of North America Pen Needles Market
- 10.1.6.4.1 Rest of North America Pen Needles Market by Type
- 10.1.6.4.2 Rest of North America Pen Needles Market by Setting
- 10.1.6.4.3 Rest of North America Pen Needles Market by Application
- 10.1.6.4.4 Rest of North America Pen Needles Market by Length
- 10.1.6.4.5 Rest of North America Pen Needles Market by Mode of Purchase
- 10.2 Europe Pen Needles Market
- 10.2.1 Europe Pen Needles Market by Type
- 10.2.1.1 Europe Standard Pen Needles Market by Country
- 10.2.1.2 Europe Safety Pen Needles Market by Country
- 10.2.2 Europe Pen Needles Market by Setting
- 10.2.2.1 Europe Homecare Market by Country
- 10.2.2.2 Europe Hospitals & Clinics Market by Country
- 10.2.2.3 Europe Others Market by Country
- 10.2.3 Europe Pen Needles Market by Application
- 10.2.3.1 Europe Insulin Market by Country
- 10.2.3.2 Europe Glucagon-like-Peptide-1 (GLP-1) Market by Country
- 10.2.3.3 Europe Growth Hormone Market by Country
- 10.2.3.4 Europe Osteoporosis Market by Country
- 10.2.3.5 Europe Others Market by Country
- 10.2.4 Europe Pen Needles Market by Length
- 10.2.4.1 Europe 8mm Market by Country
- 10.2.4.2 Europe 6mm Market by Country
- 10.2.4.3 Europe 5mm Market by Country
- 10.2.4.4 Europe 10mm Market by Country
- 10.2.4.5 Europe 12mm Market by Country
- 10.2.4.6 Europe 4mm Market by Country
- 10.2.5 Europe Pen Needles Market by Mode of Purchase
- 10.2.5.1 Europe Over the Counter Market by Country
- 10.2.5.2 Europe Prescription-based Market by Country
- 10.2.5.3 Europe Online Purchase Market by Country
- 10.2.5.4 Europe Others Market by Country
- 10.2.6 Europe Pen Needles Market by Country
- 10.2.6.1 Germany Pen Needles Market
- 10.2.6.1.1 Germany Pen Needles Market by Type
- 10.2.6.1.2 Germany Pen Needles Market by Setting
- 10.2.6.1.3 Germany Pen Needles Market by Application
- 10.2.6.1.4 Germany Pen Needles Market by Length
- 10.2.6.1.5 Germany Pen Needles Market by Mode of Purchase
- 10.2.6.2 UK Pen Needles Market
- 10.2.6.2.1 UK Pen Needles Market by Type
- 10.2.6.2.2 UK Pen Needles Market by Setting
- 10.2.6.2.3 UK Pen Needles Market by Application
- 10.2.6.2.4 UK Pen Needles Market by Length
- 10.2.6.2.5 UK Pen Needles Market by Mode of Purchase
- 10.2.6.3 France Pen Needles Market
- 10.2.6.3.1 France Pen Needles Market by Type
- 10.2.6.3.2 France Pen Needles Market by Setting
- 10.2.6.3.3 France Pen Needles Market by Application
- 10.2.6.3.4 France Pen Needles Market by Length
- 10.2.6.3.5 France Pen Needles Market by Mode of Purchase
- 10.2.6.4 Russia Pen Needles Market
- 10.2.6.4.1 Russia Pen Needles Market by Type
- 10.2.6.4.2 Russia Pen Needles Market by Setting
- 10.2.6.4.3 Russia Pen Needles Market by Application
- 10.2.6.4.4 Russia Pen Needles Market by Length
- 10.2.6.4.5 Russia Pen Needles Market by Mode of Purchase
- 10.2.6.5 Spain Pen Needles Market
- 10.2.6.5.1 Spain Pen Needles Market by Type
- 10.2.6.5.2 Spain Pen Needles Market by Setting
- 10.2.6.5.3 Spain Pen Needles Market by Application
- 10.2.6.5.4 Spain Pen Needles Market by Length
- 10.2.6.5.5 Spain Pen Needles Market by Mode of Purchase
- 10.2.6.6 Italy Pen Needles Market
- 10.2.6.6.1 Italy Pen Needles Market by Type
- 10.2.6.6.2 Italy Pen Needles Market by Setting
- 10.2.6.6.3 Italy Pen Needles Market by Application
- 10.2.6.6.4 Italy Pen Needles Market by Length
- 10.2.6.6.5 Italy Pen Needles Market by Mode of Purchase
- 10.2.6.7 Rest of Europe Pen Needles Market
- 10.2.6.7.1 Rest of Europe Pen Needles Market by Type
- 10.2.6.7.2 Rest of Europe Pen Needles Market by Setting
- 10.2.6.7.3 Rest of Europe Pen Needles Market by Application
- 10.2.6.7.4 Rest of Europe Pen Needles Market by Length
- 10.2.6.7.5 Rest of Europe Pen Needles Market by Mode of Purchase
- 10.3 Asia Pacific Pen Needles Market
- 10.3.1 Asia Pacific Pen Needles Market by Type
- 10.3.1.1 Asia Pacific Standard Pen Needles Market by Country
- 10.3.1.2 Asia Pacific Safety Pen Needles Market by Country
- 10.3.2 Asia Pacific Pen Needles Market by Setting
- 10.3.2.1 Asia Pacific Homecare Market by Country
- 10.3.2.2 Asia Pacific Hospitals & Clinics Market by Country
- 10.3.2.3 Asia Pacific Others Market by Country
- 10.3.3 Asia Pacific Pen Needles Market by Application
- 10.3.3.1 Asia Pacific Insulin Market by Country
- 10.3.3.2 Asia Pacific Glucagon-like-Peptide-1 (GLP-1) Market by Country
- 10.3.3.3 Asia Pacific Growth Hormone Market by Country
- 10.3.3.4 Asia Pacific Osteoporosis Market by Country
- 10.3.3.5 Asia Pacific Others Market by Country
- 10.3.4 Asia Pacific Pen Needles Market by Length
- 10.3.4.1 Asia Pacific 8mm Market by Country
- 10.3.4.2 Asia Pacific 6mm Market by Country
- 10.3.4.3 Asia Pacific 5mm Market by Country
- 10.3.4.4 Asia Pacific 10mm Market by Country
- 10.3.4.5 Asia Pacific 12mm Market by Country
- 10.3.4.6 Asia Pacific 4mm Market by Country
- 10.3.5 Asia Pacific Pen Needles Market by Mode of Purchase
- 10.3.5.1 Asia Pacific Over the Counter Market by Country
- 10.3.5.2 Asia Pacific Prescription-based Market by Country
- 10.3.5.3 Asia Pacific Online Purchase Market by Country
- 10.3.5.4 Asia Pacific Others Market by Country
- 10.3.6 Asia Pacific Pen Needles Market by Country
- 10.3.6.1 China Pen Needles Market
- 10.3.6.1.1 China Pen Needles Market by Type
- 10.3.6.1.2 China Pen Needles Market by Setting
- 10.3.6.1.3 China Pen Needles Market by Application
- 10.3.6.1.4 China Pen Needles Market by Length
- 10.3.6.1.5 China Pen Needles Market by Mode of Purchase
- 10.3.6.2 Japan Pen Needles Market
- 10.3.6.2.1 Japan Pen Needles Market by Type
- 10.3.6.2.2 Japan Pen Needles Market by Setting
- 10.3.6.2.3 Japan Pen Needles Market by Application
- 10.3.6.2.4 Japan Pen Needles Market by Length
- 10.3.6.2.5 Japan Pen Needles Market by Mode of Purchase
- 10.3.6.3 India Pen Needles Market
- 10.3.6.3.1 India Pen Needles Market by Type
- 10.3.6.3.2 India Pen Needles Market by Setting
- 10.3.6.3.3 India Pen Needles Market by Application
- 10.3.6.3.4 India Pen Needles Market by Length
- 10.3.6.3.5 India Pen Needles Market by Mode of Purchase
- 10.3.6.4 South Korea Pen Needles Market
- 10.3.6.4.1 South Korea Pen Needles Market by Type
- 10.3.6.4.2 South Korea Pen Needles Market by Setting
- 10.3.6.4.3 South Korea Pen Needles Market by Application
- 10.3.6.4.4 South Korea Pen Needles Market by Length
- 10.3.6.4.5 South Korea Pen Needles Market by Mode of Purchase
- 10.3.6.5 Singapore Pen Needles Market
- 10.3.6.5.1 Singapore Pen Needles Market by Type
- 10.3.6.5.2 Singapore Pen Needles Market by Setting
- 10.3.6.5.3 Singapore Pen Needles Market by Application
- 10.3.6.5.4 Singapore Pen Needles Market by Length
- 10.3.6.5.5 Singapore Pen Needles Market by Mode of Purchase
- 10.3.6.6 Malaysia Pen Needles Market
- 10.3.6.6.1 Malaysia Pen Needles Market by Type
- 10.3.6.6.2 Malaysia Pen Needles Market by Setting
- 10.3.6.6.3 Malaysia Pen Needles Market by Application
- 10.3.6.6.4 Malaysia Pen Needles Market by Length
- 10.3.6.6.5 Malaysia Pen Needles Market by Mode of Purchase
- 10.3.6.7 Rest of Asia Pacific Pen Needles Market
- 10.3.6.7.1 Rest of Asia Pacific Pen Needles Market by Type
- 10.3.6.7.2 Rest of Asia Pacific Pen Needles Market by Setting
- 10.3.6.7.3 Rest of Asia Pacific Pen Needles Market by Application
- 10.3.6.7.4 Rest of Asia Pacific Pen Needles Market by Length
- 10.3.6.7.5 Rest of Asia Pacific Pen Needles Market by Mode of Purchase
- 10.4 LAMEA Pen Needles Market
- 10.4.1 LAMEA Pen Needles Market by Type
- 10.4.1.1 LAMEA Standard Pen Needles Market by Country
- 10.4.1.2 LAMEA Safety Pen Needles Market by Country
- 10.4.2 LAMEA Pen Needles Market by Setting
- 10.4.2.1 LAMEA Homecare Market by Country
- 10.4.2.2 LAMEA Hospitals & Clinics Market by Country
- 10.4.2.3 LAMEA Others Market by Country
- 10.4.3 LAMEA Pen Needles Market by Application
- 10.4.3.1 LAMEA Insulin Market by Country
- 10.4.3.2 LAMEA Glucagon-like-Peptide-1 (GLP-1) Market by Country
- 10.4.3.3 LAMEA Growth Hormone Market by Country
- 10.4.3.4 LAMEA Osteoporosis Market by Country
- 10.4.3.5 LAMEA Others Market by Country
- 10.4.4 LAMEA Pen Needles Market by Length
- 10.4.4.1 LAMEA 8mm Market by Country
- 10.4.4.2 LAMEA 6mm Market by Country
- 10.4.4.3 LAMEA 5mm Market by Country
- 10.4.4.4 LAMEA 10mm Market by Country
- 10.4.4.5 LAMEA 12mm Market by Country
- 10.4.4.6 LAMEA 4mm Market by Country
- 10.4.5 LAMEA Pen Needles Market by Mode of Purchase
- 10.4.5.1 LAMEA Over the Counter Market by Country
- 10.4.5.2 LAMEA Prescription-based Market by Country
- 10.4.5.3 LAMEA Online Purchase Market by Country
- 10.4.5.4 LAMEA Others Market by Country
- 10.4.6 LAMEA Pen Needles Market by Country
- 10.4.6.1 Brazil Pen Needles Market
- 10.4.6.1.1 Brazil Pen Needles Market by Type
- 10.4.6.1.2 Brazil Pen Needles Market by Setting
- 10.4.6.1.3 Brazil Pen Needles Market by Application
- 10.4.6.1.4 Brazil Pen Needles Market by Length
- 10.4.6.1.5 Brazil Pen Needles Market by Mode of Purchase
- 10.4.6.2 Argentina Pen Needles Market
- 10.4.6.2.1 Argentina Pen Needles Market by Type
- 10.4.6.2.2 Argentina Pen Needles Market by Setting
- 10.4.6.2.3 Argentina Pen Needles Market by Application
- 10.4.6.2.4 Argentina Pen Needles Market by Length
- 10.4.6.2.5 Argentina Pen Needles Market by Mode of Purchase
- 10.4.6.3 UAE Pen Needles Market
- 10.4.6.3.1 UAE Pen Needles Market by Type
- 10.4.6.3.2 UAE Pen Needles Market by Setting
- 10.4.6.3.3 UAE Pen Needles Market by Application
- 10.4.6.3.4 UAE Pen Needles Market by Length
- 10.4.6.3.5 UAE Pen Needles Market by Mode of Purchase
- 10.4.6.4 Saudi Arabia Pen Needles Market
- 10.4.6.4.1 Saudi Arabia Pen Needles Market by Type
- 10.4.6.4.2 Saudi Arabia Pen Needles Market by Setting
- 10.4.6.4.3 Saudi Arabia Pen Needles Market by Application
- 10.4.6.4.4 Saudi Arabia Pen Needles Market by Length
- 10.4.6.4.5 Saudi Arabia Pen Needles Market by Mode of Purchase
- 10.4.6.5 South Africa Pen Needles Market
- 10.4.6.5.1 South Africa Pen Needles Market by Type
- 10.4.6.5.2 South Africa Pen Needles Market by Setting
- 10.4.6.5.3 South Africa Pen Needles Market by Application
- 10.4.6.5.4 South Africa Pen Needles Market by Length
- 10.4.6.5.5 South Africa Pen Needles Market by Mode of Purchase
- 10.4.6.6 Nigeria Pen Needles Market
- 10.4.6.6.1 Nigeria Pen Needles Market by Type
- 10.4.6.6.2 Nigeria Pen Needles Market by Setting
- 10.4.6.6.3 Nigeria Pen Needles Market by Application
- 10.4.6.6.4 Nigeria Pen Needles Market by Length
- 10.4.6.6.5 Nigeria Pen Needles Market by Mode of Purchase
- 10.4.6.7 Rest of LAMEA Pen Needles Market
- 10.4.6.7.1 Rest of LAMEA Pen Needles Market by Type
- 10.4.6.7.2 Rest of LAMEA Pen Needles Market by Setting
- 10.4.6.7.3 Rest of LAMEA Pen Needles Market by Application
- 10.4.6.7.4 Rest of LAMEA Pen Needles Market by Length
- 10.4.6.7.5 Rest of LAMEA Pen Needles Market by Mode of Purchase
Chapter 11. Company Profiles
- 11.1 Embecta Corp.
- 11.1.1 Company Overview
- 11.1.2 Financial Analysis
- 11.1.3 Regional Analysis
- 11.1.4 Research & Development Expenses
- 11.1.5 Recent strategies and developments:
- 11.1.5.1 Partnerships, Collaborations, and Agreements:
- 11.1.6 SWOT Analysis
- 11.2 Owen Mumford Limited
- 11.2.1 Company Overview
- 11.2.2 Recent strategies and developments:
- 11.2.2.1 Partnerships, Collaborations, and Agreements:
- 11.2.2.2 Product Launches and Product Expansions:
- 11.2.3 SWOT Analysis
- 11.3 Novo Nordisk A/S
- 11.3.1 Company Overview
- 11.3.2 Financial Analysis
- 11.3.3 Segmental & Regional Analysis
- 11.3.4 Research & Development Expenses
- 11.3.5 Recent strategies and developments:
- 11.3.5.1 Partnerships, Collaborations, and Agreements:
- 11.3.5.2 Acquisition and Mergers:
- 11.3.5.3 Geographical Expansions:
- 11.3.6 SWOT Analysis
- 11.4 Ypsomed AG
- 11.4.1 Company Overview
- 11.4.2 Financial Analysis
- 11.4.3 Segmental and Regional Analysis
- 11.4.4 Recent strategies and developments:
- 11.4.4.1 Partnerships, Collaborations, and Agreements:
- 11.4.4.2 Product Launches and Product Expansions:
- 11.4.5 SWOT Analysis
- 11.5 B. Braun Melsungen AG
- 11.5.1 Company Overview
- 11.5.2 Financial Analysis
- 11.5.3 Segmental and Regional Analysis
- 11.5.4 Research & Development Expenses
- 11.5.5 Recent strategies and developments:
- 11.5.5.1 Partnerships, Collaborations, and Agreements:
- 11.5.5.2 Acquisition and Mergers:
- 11.5.6 SWOT Analysis
- 11.6 Terumo Corporation
- 11.6.1 Company Overview
- 11.6.2 Financial Analysis
- 11.6.3 Segmental and Regional Analysis
- 11.6.4 Research & Development Expenses
- 11.6.5 Recent strategies and developments:
- 11.6.5.1 Partnerships, Collaborations, and Agreements:
- 11.6.5.2 Product Launches and Product Expansions:
- 11.6.6 SWOT Analysis
- 11.7 Nipro Corporation
- 11.7.1 Company Overview
- 11.7.2 Financial Analysis
- 11.7.3 Segmental and Regional Analysis
- 11.7.4 Research & Development Expenses
- 11.7.5 Recent strategies and developments:
- 11.7.5.1 Partnerships, Collaborations, and Agreements:
- 11.8 Arkray, Inc.
- 11.8.1 Company Overview
- 11.8.2 SWOT Analysis
- 11.9 UltiMed, Inc.
- 11.10. Allison Medical, Inc.
Chapter 12. Winning Imperatives for Pen Needles market